Frank Bellivier, MD, PhD

  • 6Articles
  • 26.3KReads
  • 2003–2025Active
  • 65Collaborators
  • 344Citations

About

Frank Bellivier, MD, PhD, is affiliated with Optimisation Thérapeutique en Neuropsychopharmacologie, UMR-S1144 Team 1, Inserm, Université Paris Cité, Paris, France, and APHP, Hôpital Lariboisière – Fernand Widal, Département Universitaire de Psychiatrie et de Médecine Addictologique, Paris, France. The author has published six articles between 2003 and 2025 on topics including bipolar disorder, suicide, anxiety, and anxiolytics. Frequent collaborators include Bruno Etain, Chantal Henry, Marion Leboyer, Frédéric Rouillon, and Guillaume Vaiva.

Publications

JCP
Bright Light Therapy in the Morning or Midday for Nonseasonal Depression in Bipolar Disorder
Original Research

Bright Light Therapy in the Morning or Midday for Nonseasonal Depression in Bipolar Disorder

June 23, 2025

Bright light therapy is well tolerated in bipolar disorder, starting at 45 minutes/day, with only 6% of patients experiencing a hypomanic switch and 13% experiencing subsyndromic symptoms, which resolved...
, , , et al
JCP
Original Research

Brief Contact Interventions as Suicide Prevention Strategies

September 25, 2018

Once a patient is discharged after a suicide attempt, what can be done to prevent another attempt? This study evaluated a suicide prevention strategy algorithm versus treatment as usual...
, , , et al
JCP
Original Research

Childhood Trauma Is Associated With Severe Clinical Characteristics of Bipolar Disorders

October 15, 2013

, , , et al
JCP
Original Research

Clinical Expression of Bipolar Disorder Type I as a Function of Age and Polarity at Onset: Convergent Findings in Samples From France and the United States

April 15, 2012

, , , et al
JCP
Original Research

Bipolar Patients With Suicidal Behavior: Toward the Identification of a Clinical Subgroup

August 16, 2004

, , , et al
JCP
Original Research

Anxiety Disorders in 318 Bipolar Patients: Prevalence and Impact on Illness Severity and Response to Mood Stabilizer.

March 15, 2003

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe